Cargando…

Personal View: Low-Dose Lung Radiotherapy Should be Evaluated as a Treatment for Severe COVID-19 Lung Disease

Detalles Bibliográficos
Autores principales:	Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E., Chalmers, A.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of The Royal College of Radiologists. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427522/ https://www.ncbi.nlm.nih.gov/pubmed/32829986 http://dx.doi.org/10.1016/j.clon.2020.08.003

Ejemplares similares

Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia – The Atypical Science and the Unknown Collateral Consequence
por: Tharmalingam, H., et al.
Publicado: (2020)

EGFR targeted therapy in lung cancer; an evolving story
por: Bartholomew, C., et al.
Publicado: (2017)

Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
por: Lewis, T.S., et al.
Publicado: (2020)

Effect of atelectasis changes on tissue mass and dose during lung radiotherapy
por: Guy, Christopher L., et al.
Publicado: (2016)

Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022)

203MO Changes in management for patients with lung cancer treated with radical radiotherapy during the first wave of the COVID-19 pandemic in the UK (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

PO-1916 Low-dose lung radiotherapy for COVID-19 pneumonia: preclinical studies in bleomycin pneumonitis
por: Chalmers, A., et al.
Publicado: (2021)

P09.17 Changes in the Management of Patients Having Radical Radiotherapy in the UK During the COVID-19 Pandemic (COVID-RT Lung)
por: Banfill, K., et al.
Publicado: (2021)

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Zahid, Mohammad U., et al.
Publicado: (2021)

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
por: Faivre-Finn, C., et al.
Publicado: (2020)

Lung dose analysis in loco-regional hypofractionated radiotherapy of breast cancer
por: Attar, Mohammad A., et al.
Publicado: (2016)

Optimizing the management of advanced non-small-cell lung cancer: a personal view
por: Vincent, M.D.
Publicado: (2009)

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy
por: Ouyang, Zi, et al.
Publicado: (2021)

Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?
por: Saffarzadeh, Areo G., et al.
Publicado: (2021)

Should sublobar resection be offered for screening-detected lung nodules?
por: Sihoe, Alan D. L.
Publicado: (2021)

PO-1198 Changes in radical radiotherapy for lung cancer patients in the UK during the COVID-19 pandemic.
por: croxford, W., et al.
Publicado: (2021)

Reducing dose to the lungs through loosing target dose homogeneity requirement for radiotherapy of non small cell lung cancer
por: Miao, Junjie, et al.
Publicado: (2017)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Static lung volume should be used to confirm restrictive lung disease
por: Rasam, Shweta A, et al.
Publicado: (2016)

Dose and fractionation schedules in radiotherapy for non-small cell lung cancer
por: Kepka, Lucyna, et al.
Publicado: (2021)

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010–2015
por: Aznar, Marianne C., et al.
Publicado: (2018)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Dosimetric evaluation of four‐dimensional dose distributions of CyberKnife and volumetric‐modulated arc radiotherapy in stereotactic body lung radiotherapy
por: Chan, Mark K.H., et al.
Publicado: (2013)

A national survey of lung cancer specialists’ views on low-dose CT screening for lung cancer in Korea
por: Shin, Dong Wook, et al.
Publicado: (2018)

To what extent should the intestinal be resected proximally after radiotherapy: hint from a pathological view
por: Wu, Pei-Huang, et al.
Publicado: (2019)

Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
por: Al Feghali, Karine A., et al.
Publicado: (2020)

Supporting older people with cancer, implementing geriatric oncology in the radiotherapy setting
por: Morris, Lucinda, et al.
Publicado: (2020)

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma
por: Ashton, M., et al.
Publicado: (2017)

The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based Study
por: Grocutt, L., et al.
Publicado: (2023)

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
por: Anderson, Justin D., et al.
Publicado: (2021)

Radiation Exposure to Low-Dose Computed Tomography for Lung Cancer Screening: Should We Be Concerned?
por: Pozzessere, Chiara, et al.
Publicado: (2023)

Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment
por: Gupta, Sweety, et al.
Publicado: (2021)

Changes in management for patients with lung cancer referred for radical radiotherapy during the first wave of the COVID 19 pandemic in the UK (COVID-RT Lung)
por: Banfill, Kathryn Banfill, et al.
Publicado: (2021)

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK
por: Banfill, K., et al.
Publicado: (2022)

Learning curve of lung dose optimization in intensity‐modulated radiotherapy for locally advanced non‐small cell lung cancer
por: Igari, Mitsunobu, et al.
Publicado: (2023)

Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
por: Fodor, Andrei, et al.
Publicado: (2020)

Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors
por: Park, Sungkwang, et al.
Publicado: (2014)

Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
por: Peng, Jiayuan, et al.
Publicado: (2016)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?
por: Nieder, Carsten, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_47eadpsvcvk7jajsl9s8gna14n